Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase.
about
A rationally designed peptide enhances homologous recombination in vitro and resistance to DNA damaging agents in vivo.Cellular responses to Cisplatin-induced DNA damage.Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor.Use of antidepressants and NSAIDs in relation to mortality in long-term breast cancer survivors.Dense collagen-I matrices enhance pro-tumorigenic estrogen-prolactin crosstalk in MCF-7 and T47D breast cancer cells.Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck.Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.Lactogens and estrogens in breast cancer chemoresistance.Expression of glutathione, glutathione peroxidase and glutathione S-transferase pi in canine mammary tumorsLower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas.Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer.Autocrine prolactin: an emerging market for homegrown (prolactin) despite the imports.Prolactin Promotes Breast Cancer Cell Migration through Actin Cytoskeleton Remodeling.Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse.Pineal Diffuse Large B-Cell Lymphoma Concomitant With Pituitary Prolactinoma: Possible Correlation Between 2 Distinguished Pathologies: A Case Report.Synergistic effect between cisplatin and sunitinib malate on human urinary bladder-cancer cell lines.Hypothesis: prolactin is tumorigenic to human breast: dispelling the myth that prolactin-induced mammary tumors are rodent-specific.Involvement of miR-106b in tumorigenic actions of both prolactin and estradiolCombination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway.Acetazolamide triggers death inducing autophagy in T-47D breast cancer cells.Breast carcinomas with hyperprolactinemia at the time of diagnosis-clinico-biological association.
P2860
Q34020252-095E5971-7203-44CB-B8EA-B1F688E9D2D8Q34089685-7CB54DD3-4CEE-47AF-B181-C5329E929041Q34258777-C54DAA15-8735-46FC-A7DA-92020A453B3CQ34778824-D2E56976-A43C-4D7E-8988-F96DB25BFA6CQ34994336-78E322CA-F4C0-4154-981B-DC6C829A0381Q35006785-DF135D24-618C-4AA3-8F4D-8A05C4499E44Q35029548-B3D42E61-1AC9-4B56-AD1F-AC4147A51D58Q35075176-396A148C-0E0D-46AE-B45F-8ADA2074CC9DQ35102082-9D74F013-469A-4C7A-8023-7B65D3E79CF6Q35530288-52D8D491-2928-47B2-B8B1-B8F2E105EFB9Q35709343-945A3DAD-1488-4755-87C5-BB49AD18A4F1Q36331355-97670733-B053-4F43-8ED1-8495556D17F4Q36378657-33E17921-23A2-4172-9187-18CB3BC71FF5Q36629985-9874B0F9-497F-487B-81EB-EC5EE673F6EEQ36653701-57F4614B-6A6B-4152-A947-C94E79FCEDB5Q37392963-48CEA0A2-9ED1-4432-A0AC-60D53EA3C28DQ37957807-CC2ABA79-A5A9-455B-B44F-5C937BBC955DQ38706936-CF811ACE-53A4-40F2-9B13-61F5957F0690Q39060605-DF3A4D07-F8D8-47B6-B0E2-CD51D56AD818Q39071997-507C6980-B24D-4852-8608-0B63452C3DE0Q43706172-B9EA7A34-80BD-478F-B840-87476D7760EE
P2860
Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prolactin confers resistance a ...... ing glutathione-S-transferase.
@en
Prolactin confers resistance a ...... ing glutathione-S-transferase.
@nl
type
label
Prolactin confers resistance a ...... ing glutathione-S-transferase.
@en
Prolactin confers resistance a ...... ing glutathione-S-transferase.
@nl
prefLabel
Prolactin confers resistance a ...... ing glutathione-S-transferase.
@en
Prolactin confers resistance a ...... ing glutathione-S-transferase.
@nl
P2093
P2860
P356
P1433
P1476
Prolactin confers resistance a ...... ing glutathione-S-transferase.
@en
P2093
Christopher R LaPensee
El Mustapha Bahassi
Elizabeth W LaPensee
Sandy J Schwemberger
Scott E Afton
P2860
P304
P356
10.1093/CARCIN/BGP120
P407
P577
2009-05-14T00:00:00Z